Biotricity (BTCY) Competitors $0.42 +0.03 (+7.72%) As of 12:01 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock BTCY vs. ECOR, BDMD, PYPD, POCI, NMTC, TMDIF, DRIO, COCH, OSRH, and FEMYShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include electroCore (ECOR), Baird Medical Investment (BDMD), PolyPid (PYPD), Precision Optics (POCI), NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), DarioHealth (DRIO), Envoy Medical (COCH), OSR (OSRH), and Femasys (FEMY). These companies are all part of the "medical equipment" industry. Biotricity vs. Its Competitors electroCore Baird Medical Investment PolyPid Precision Optics NeuroOne Medical Technologies Titan Medical DarioHealth Envoy Medical OSR Femasys Biotricity (NASDAQ:BTCY) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Does the media favor BTCY or ECOR? In the previous week, Biotricity and Biotricity both had 1 articles in the media. Biotricity's average media sentiment score of 0.00 equaled electroCore'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biotricity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral electroCore 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, BTCY or ECOR? electroCore has higher revenue and earnings than Biotricity. electroCore is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiotricity$12.06M0.87-$14.09M-$1.08-0.39electroCore$25.18M1.78-$11.89M-$1.56-3.87 Is BTCY or ECOR more profitable? electroCore has a net margin of -46.24% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets Biotricity-80.42% N/A -188.47% electroCore -46.24%-149.04%-61.24% Which has more volatility and risk, BTCY or ECOR? Biotricity has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Do institutionals and insiders hold more shares of BTCY or ECOR? 3.9% of Biotricity shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Comparatively, 19.7% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend BTCY or ECOR? electroCore has a consensus price target of $25.50, suggesting a potential upside of 322.82%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Biotricity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryelectroCore beats Biotricity on 10 of the 14 factors compared between the two stocks. Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.47M$248.27M$5.50B$9.01BDividend YieldN/AN/A5.39%4.11%P/E Ratio-0.395.9127.4220.07Price / Sales0.8770.57398.50109.13Price / CashN/A196.1236.1356.90Price / Book-0.326.138.015.70Net Income-$14.09M-$26.71M$3.16B$248.47M7 Day Performance13.54%-1.78%2.08%2.92%1 Month Performance-11.48%-6.36%4.38%5.77%1 Year Performance-46.51%24.49%35.81%21.39% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.42+7.7%N/A-48.7%$10.47M$12.06M-0.3940News CoverageGap DownECORelectroCore2.8028 of 5 stars$5.41+5.5%$25.50+371.3%-15.2%$38.07M$25.18M-3.4750BDMDBaird Medical InvestmentN/A$6.39+11.7%N/AN/A$37.66MN/A0.00N/AGap UpPYPDPolyPid2.575 of 5 stars$3.58-2.7%$11.80+229.6%-12.8%$37.50MN/A-0.8380High Trading VolumePOCIPrecision Optics0.8352 of 5 stars$4.60-0.9%N/A-20.5%$35.57M$19.10M-5.1780NMTCNeuroOne Medical Technologies3.0881 of 5 stars$0.69+4.8%$1.45+108.9%-20.6%$32.99M$3.45M-3.1620Positive NewsHigh Trading VolumeTMDIFTitan MedicalN/A$0.28+31.4%N/A+670.5%$32.37M$17.63M-0.2350Gap UpDRIODarioHealth1.7414 of 5 stars$0.72+4.8%$2.00+178.6%-39.8%$30.47M$27.04M-1.28200COCHEnvoy Medical2.8006 of 5 stars$1.42+1.4%$9.25+551.4%-32.1%$29.86M$220K-1.0334Gap DownOSRHOSRN/A$1.28-2.3%N/AN/A$25.25MN/A0.00N/AGap DownFEMYFemasys3.7276 of 5 stars$0.89-1.8%$8.67+879.3%-14.4%$23.02M$1.63M-0.9730 Related Companies and Tools Related Companies electroCore Alternatives Baird Medical Investment Alternatives PolyPid Alternatives Precision Optics Alternatives NeuroOne Medical Technologies Alternatives Titan Medical Alternatives DarioHealth Alternatives Envoy Medical Alternatives OSR Alternatives Femasys Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTCY) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTCY Stock Alerts